about
Control of adipocyte differentiation in different fat depots; implications for pathophysiology or therapyAdipocytes: impact on tumor growth and potential sites for therapeutic interventionBacterial translocation - impact on the adipocyte compartmentFNDC5/irisin is not only a myokine but also an adipokineNew insights into pancreatic cancer-induced paraneoplastic diabetesImproved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiomeDevelopmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight femalesVisceral fat is associated with lower brain volume in healthy middle-aged adults.Improvements in vascular health by a low-fat diet, but not a high-fat diet, are mediated by changes in adipocyte biology.Hyperglycemic Challenge and Distribution of Adipose Tissue in Obese Baboons.Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.Metabolic syndrome: definitions and controversies.Adiponectin, a key adipokine in obesity related liver diseasesSonographic evaluation of visceral and subcutaneous fat in obese childrenAdiponectin: an adipokine with protective features against metabolic syndrome.Intermuscular and intramuscular adipose tissues: Bad vs. good adipose tissues.The Role of Body Fat and Fat Distribution in Hypertension Risk in Urban Black South African WomenLeft ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor.Serum Levels of Soluble CD26/Dipeptidyl Peptidase-IV in Type 2 Diabetes Mellitus and Its Association with Metabolic Syndrome and Therapy with Antidiabetic Agents in Malaysian SubjectsDevelopmental origins of obesity: programmed adipogenesisAdipocytokines, metabolic syndrome, and exercise.Is adipose tissue metabolically different at different sites?Vitamin d and metabolic syndrome risk factors: evidence and mechanisms.Metabolic syndrome in patients with hematological diseases.Identification of Mouse Mesenteric and Subcutaneous in vitro Adipogenic Cells.Dietary regulation of adiponectin by direct and indirect lipid activators of nuclear hormone receptors.Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Improvements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations.Early changes of abdominal adiposity detected with weekly dual bioelectrical impedance analysis during calorie restriction.Human subcutaneous adipose tissue Glut 4 mRNA expression in obesity and type 2 diabetes.Effects of monthly feedback of VFA measured by dual BIA method in Japanese patients with obesity: a randomized controlled study.Visceral Adiposity in Psoriasis is Associated With Vascular Inflammation by (18)Fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography Beyond Cardiometabolic Disease Risk Factors in an Observational Cohort Study.Sexual dimorphism in adipose tissue function as evidenced by circulating adipokine concentrations in the fasting state and after an oral glucose challenge.Trefoil factor family member 2 (Tff2) KO mice are protected from high-fat diet-induced obesity.Improvement of fasting plasma glucose level after ingesting moderate amount of dietary fiber in Japanese men with mild hyperglycemia and visceral fat obesity.Computed tomography-based assessment of abdominal adiposity changes and their impact on metabolic alterations following bariatric surgery.Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk.Increase in Adiponectin Level Prevents the Development of Type 2 Diabetes in Japanese Men With Low Adiponectin Levels.
P2860
Q26825739-734EBC84-903A-411F-93F1-3FB3A4D2F49CQ26830077-11B0EC9C-C785-4034-8D43-11DDE9525F8FQ26852238-43DEB2BF-447F-43EA-A585-C2395060CBB2Q27329974-D754A232-BF97-4B1E-A681-D17C6991B184Q27687766-7FE04C4D-1ABE-4FFA-BEAB-698B07F7BA65Q28070321-D56F816B-A40C-4D4E-8F6C-F4D9D65B4945Q33634370-A2FF8C28-01C3-4690-BCE0-6FC9944A5D87Q34105185-82FF434D-2DDA-4C15-A54C-D9F39629B445Q34547045-A43CD09F-2EAA-44F7-8D42-91A7EA14A761Q34561902-E3321B79-FD91-4EDD-8CB5-8576654CC8FDQ34718822-7628C181-ACAA-4D54-961E-4481E651A269Q35047747-C335C23D-E831-4748-98A7-BE3AA87D68EDQ35061908-F177EC82-F2CE-4800-A439-09922C937FA0Q35109811-08100B51-945D-4757-AF5B-7A90E9462D8EQ35763433-D6A5E2EB-1AF9-4153-A6A9-258F4AAE6D9CQ35998810-77E4E40B-DFA7-447A-ACBB-DADE5502BDC5Q36015326-F1E99D10-2348-4525-8542-3EC2DAB0884DQ36152894-3E054BDC-43E5-45D1-9212-7CBEE5EFA4D3Q36170755-E6E47633-314B-4B71-B13E-D5E7DADBE3F2Q36584588-95A97FF9-80FD-42ED-9C36-AF8C6DA38310Q37664656-E1BD49A2-6F51-4DC7-B9F2-5E92C8138C5EQ37929761-8A2318DF-D0EC-4BC7-8423-39080320441AQ37953480-14708ABB-1CDE-4DA9-8795-69D249C224EDQ38044776-74151244-397B-4422-9B8F-414CD7907BF3Q38529083-BDD79D28-63A5-4CFA-A621-99F2314F0B33Q38648917-B1FC828C-32CE-4759-BE28-69B757B39488Q40707324-09DCF934-5425-4CD6-A074-2E76204C514DQ43124456-3CAC3257-070D-4F43-9CA4-894234166A71Q46189952-5AAD4368-D9D2-4791-B3DB-6301DCE3B589Q46445171-2CBBA007-ED8F-495C-B819-9D7AD92961C1Q47126674-1202BA0D-503F-4C52-A325-19FD6A5CEE45Q47884794-FD55501C-C43F-49FB-91D3-2981A6B6AF0FQ50492761-9758A3E8-CD6A-4AFF-84F4-1448E9B2645FQ50919596-325B422D-2FCF-4AD5-AD71-353F95BC8622Q51339693-3136FDE1-7FF8-4C9A-817B-C765943DECF1Q53044458-6439BCBF-D308-4BC1-8386-6D5431633F61Q55259913-197E47C3-1D9F-4FCF-80D2-01F9F83BFB4EQ55426265-10076E84-3ACF-4CC8-B8B3-13B82CE5454C
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of fat topology in the risk of disease.
@en
The role of fat topology in the risk of disease.
@nl
type
label
The role of fat topology in the risk of disease.
@en
The role of fat topology in the risk of disease.
@nl
prefLabel
The role of fat topology in the risk of disease.
@en
The role of fat topology in the risk of disease.
@nl
P2860
P356
P1476
The role of fat topology in the risk of disease.
@en
P2093
Y Matsuzawa
P2860
P2888
P304
P356
10.1038/IJO.2008.243
P407
P478
32 Suppl 7
P577
2008-12-01T00:00:00Z